Skip to main content
. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593

1.50. Analysis.

1.50

Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 50 Number who suffered at least one adverse event of urinary tract infection before end of treatment at 6 month.